Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
356
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+421K
-
Total reported value, excl. options
-
$6.67B
-
Value change
-
+$40.6M
-
Put/Call ratio
-
0.44
-
Number of buys
-
160
-
Number of sells
-
-151
-
Price
-
$56.54
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2020
429 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2020.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 356 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 159M outstanding shares and own 74.45% of the company stock.
Largest 10 shareholders include FMR LLC (20.9M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.1M shares), VANGUARD GROUP INC (12.2M shares), BlackRock Inc. (9.75M shares), Bellevue Group AG (9.05M shares), Clearbridge Investments, LLC (6.92M shares), STATE STREET CORP (3.91M shares), Invesco Ltd. (3.38M shares), ARK Investment Management LLC (2.4M shares), and WADDELL & REED FINANCIAL INC (2.15M shares).
This table shows the top 356 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.